Publication | Open Access
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia
31
Citations
15
References
2022
Year
Long CovidSevere HypoxaemiaHematologyMedicineLong-term OutcomesCovid-19Dexamethasone 12
| Year | Citations | |
|---|---|---|
Page 1
Page 1